How Much Did OptimizeRx Raise?
Funding & Key Investors

OptimizeRx, a technology solutions provider for the healthcare industry, has secured significant capital, with its total funding reaching $34.9M. The company recently announced a major strategic investment of $20M, underscoring its pivotal role in facilitating direct communication channels between pharmaceutical manufacturers and both consumers and physicians. This latest financing round signifies a substantial endorsement of OptimizeRx's innovative approach to pharmaceutical promotion and market engagement.

What is OptimizeRx?

OptimizeRx
Business ServicesSoftware TestingAdvertising Networks

OptimizeRx Corporation operates within the health tech sector, specializing in technology solutions designed to enhance communication and promotion within the healthcare industry. Based in Rochester, Michigan, the company empowers pharmaceutical manufacturers by providing direct-to-consumer and direct-to-physician channels. This strategic positioning allows for more targeted and effective product promotion, bridging the gap between healthcare providers, patients, and pharmaceutical companies. The company's focus on innovative communication strategies addresses evolving market demands for efficient and data-driven engagement.

How much funding has OptimizeRx raised?

OptimizeRx has raised a total of $34.9M across 4 funding rounds:

2010

Other Financing Round

$3M

2018

Share Placement

$9M

Stock Offering

$2.9M

2019

Stock Offering

$20M

Other Financing Round (2010): $3M, investors not publicly disclosed

Share Placement (2018): $9M led by The Special Situations Funds

Stock Issuance/Offering (2018): $2.9M, investors not publicly disclosed

Stock Issuance/Offering (2019): $20M, investors not publicly disclosed

Key Investors in OptimizeRx

The Special Situations Funds

The Special Situations Funds provided backing through a share placement, indicating a strategic interest in OptimizeRx's market position and growth potential.

What's next for OptimizeRx?

With a recent major strategic investment and a substantial overall funding history of $34.9M, OptimizeRx is poised for accelerated growth and market expansion. The enterprise-level capital infusion suggests a strategic focus on scaling operations, enhancing its technology platform, and potentially broadening its service offerings to the pharmaceutical sector. This backing is likely to fuel further innovation in digital health communication, reinforcing OptimizeRx's position as a key enabler for pharmaceutical marketing strategies. The company's trajectory indicates a strong emphasis on leveraging technology to optimize patient and physician engagement in the pharmaceutical landscape.

See full OptimizeRx company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject Management
Accounting for Legal PracticesBusiness Services
Business ServicesHuman Resources Management Systems (HRMS)
Business ServicesResearch & DevelopmentConsumer ServicesSoftware TestingRepair Services

Frequently Asked Questions Regarding OptimizeRx Financial Insights

What are the most recent funding rounds that OptimizeRx has completed, and what were the funding rounds?
OptimizeRx has recently completed 3 funding rounds: Stock Offering on Jun 5, 2019, Stock Offering on Dec 20, 2018, Share Placement on May 11, 2018.
What is the total amount of funding OptimizeRx has raised to date?
OptimizeRx has raised a total of $34.9M in funding to date.
How many funding rounds has OptimizeRx completed?
OptimizeRx has completed 3 funding rounds.
How much funding did OptimizeRx raise in its most recent funding round?
OptimizeRx raised $20M in its most recent funding round.
Which was the largest funding round in OptimizeRx's history?
The largest funding round in OptimizeRx's history was $20M.
See more information about OptimizeRx